Ecallantide peptide
Ecallantide is a real peptide or peptide-based medicine with regulated uses. Approval, formulation and indication depend on jurisdiction and product.
Use this Ecallantide peptide record to separate compound identity, human evidence, regulatory status and COA quality. These are related but distinct questions.
What is Ecallantide?
Ecallantide is a recombinant peptide inhibitor of plasma kallikrein.
What does it do?
It reduces formation of bradykinin by inhibiting kallikrein activity.
Current use and status
Authorized use is limited to acute attacks of a specific hereditary angioedema condition.
Approved prescription medicine for specific uses in at least one jurisdiction.
What the evidence does not prove
Serious hypersensitivity risk and diagnosis-specific use require monitored clinical care.
Certificate quality signals
- Certificate lot and label lot should agree
- Measured values should name their analytical method
- The issuing laboratory and report identifier should be independently traceable
Ecallantide peptide reference records
Use the public chemistry and regulatory or clinical-study records to confirm identity and current product status. A database listing is not a product endorsement.
Learn how to assess peptide evidence
Read the peptide safety, sourcing and certificate-verification guides before interpreting a seller or laboratory claim.
Browse peptide guides